NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.99
+1.07 (0.52%)
AAPL  269.00
-3.95 (-1.45%)
AMD  200.84
-2.84 (-1.39%)
BAC  50.12
-2.17 (-4.16%)
GOOG  308.59
+1.44 (0.47%)
META  646.55
-10.46 (-1.59%)
MSFT  395.25
-6.47 (-1.61%)
NVDA  181.63
-3.26 (-1.76%)
ORCL  145.35
-4.96 (-3.30%)
TSLA  405.42
-3.16 (-0.77%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.